[2]. Arakida Y, et al. Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs. J Pharmacol Exp Ther. 1999 Sep;290(3):1285-91.
[1]. Arakida Y, et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD 4 and TXA 2 receptors. J Pharmacol Exp Ther. 1998 Nov;287(2):633-9.
[1]. Arakida Y, et al. In vitro pharmacologic profile of YM158, a new dual antagonist for LTD 4 and TXA 2 receptors. J Pharmacol Exp Ther. 1998 Nov;287(2):633-9.
[2]. Arakida Y, et al. Effects of lipid mediator antagonists on predominant mediator-controlled asthmatic reactions in passively sensitized guinea pigs. J Pharmacol Exp Ther. 1999 Sep;290(3):1285-91.